Shares of HIMS experienced a dramatic decline today following the unexpected withdrawal of its agreement with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending HIMS's stock price plummeting by nearly fifteen percent. The reason for the collapse of the partnership remains unclear, but industry analysts speculate